# A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomised-phase-ii-study-investigating-durvalumab-in-addition-to-an/

## Facts

| Field | Value |
| --- | --- |
| Author Names | S. Loibl,Michael Untch,Nicole Burchardi,Jens Huober,Bruno V. Sinn,Jens‐Uwe Blohmer,Eva‐Maria Grischke,Jenny Furlanetto,Hans Tesch,Claus Hanusch,Knut Engels,Mahdi Rezai,Christian Jackisch,Wolfgang Schmitt,Gϋnter von Minckwitz,Jörg Thomalla,Sherko Kümmel,Beate Rautenberg,Peter A. Fasching,Karsten E. Weber,Kerstin Rhiem,Carsten Denkert,Andreas Schneeweiß |
| Citations | 706 |
| DOI | 10.1093/annonc/mdz158 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2946550606 |
| PMID | 31095287 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Jens‐Uwe Blohmer](https://scholariq.org/researchers/jens-uwe-blohmer/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.